Tag: Drug Repurposing
-
Old Drugs, New Hope: How a Pioneering Trial Uses Familiar Antibiotics to Save Babies from Sepsis
Introduction: A quiet revolution in neonatal care In a sunlit clinic near Kenya’s Kilifi Creek, a team of clinicians, microbiologists, and researchers is tackling one of medicine’s toughest challenges: sepsis in newborns. The NeoSep1 trial is testing a bold idea—using older, well-known antibiotics in new combinations to outpace resistance and improve survival for some of…
-
Gnome Sciences Unveils Promising ALS Results From Cancer Drug Study
Groundbreaking ALS Findings from a Cancer Drug Study Gnome Sciences, a leader in molecular pathology and translational research, announced a significant advance in the fight against amyotrophic lateral sclerosis (ALS). In a newly published study, researchers revealed that a cancer drug—originally developed to target tumor growth—demonstrated measurable neuroprotective effects in ALS models. The findings, produced…
-
ALS Breakthrough: Cancer Drug Shows Promise, Gnome Sciences Reports
Gnome Sciences Announces Promising ALS Research Gnome Sciences, a leader in molecular pathology and translational research, has announced encouraging results from a newly published study investigating the potential of a cancer drug in treating amyotrophic lateral sclerosis (ALS). The announcement, made in Columbus, Ohio, underscores a growing interest in repurposing oncology therapies to address complex…
-
Gnome Sciences Announces Cancer Drug Shows Promise for ALS Therapy in New Study
Breakthrough in ALS Research: A Cancer Drug Shows Promise In a notable advance for neurodegenerative disease research, Gnome Sciences, a leader in molecular pathology and translational studies, reports that a cancer drug demonstrates promising effects in models of amyotrophic lateral sclerosis (ALS). The company announced the findings following a newly published study that suggests the…
-
CPD Gene Mutations Reveal New Path to Rare Congenital Hearing Loss
Introduction: A New Clue in Rare Congenital Hearing Loss A multinational team of researchers has identified mutations in the CPD gene that contribute to a rare form of congenital hearing loss. The findings, published in the Journal of Clinical Investigation, illuminate how a gene long associated with protein modification can also influence the inner ear.…
-
CPD Gene Mutations Reveal Pathway to Rare Congenital Hearing Loss and New Treatment Avenues
New Insights into a Rare Cause of Congenital Hearing Loss A multinational team of researchers has identified mutations in a gene known as CPD as a key factor in a rare form of congenital hearing loss. Published in the Journal of Clinical Investigation, the study from scientists at the University of Chicago, the University of…
-
UChicago Scientists Link CPD Gene Mutation to Deafness and Identify Potential Treatments
New Discoveries Connect CPD Mutations to Congenital Deafness A multinational team of scientists has identified a gene mutation in CPD that plays a crucial role in a rare form of congenital hearing loss. The collaborative study, conducted by researchers from the University of Chicago, the University of Miami, and several Turkish institutions, was published in…
-
Fatty Liver Cure: Could Pemafibrate and Telmisartan Reversethe Disease?
New Study Suggests a Surprising Duo for Fatty Liver Cure Fatty liver disease, or MASLD/NAFLD as it’s increasingly called, has earned its reputation as a global silent killer. The condition unfolds quietly as excess fat accumulates in liver cells, potentially progressing to inflammation, fibrosis, and even cirrhosis or liver cancer. While lifestyle changes remain the…
-
Fatty Liver Cure: Pemafibrate and Telmisartan Combo May Reverse MASLD
New hope in fatty liver disease: a drug combination that could reverse MASLD Fatty liver disease, now increasingly called MASLD (Metabolic Associated Steatosis with Liver Disease), affects millions worldwide and is rising in prevalence alongside obesity and sedentary lifestyles. While lifestyle changes remain essential, researchers have long searched for therapies that can halt or reverse…
-
Fatty Liver Cure: How Two Common Cardiovascular Drugs Could Reverses Fatty Liver Disease
The Breakthrough: A New Hope for Fatty Liver Disease Fatty liver disease, or MASLD (formerly NAFLD), affects millions worldwide and has long lacked a proven medical cure. A recent study from researchers at the University of Barcelona suggests a provocative approach: combining two widely used cardiovascular drugs—pemafibrate and telmisartan—to actively reduce liver fat and improve…